Ebronucimab

DRUG2 trials

Sponsors

Akeso

Conditions

Healthy SubjectsHealthy Subjects (HS)

Phase 1

A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Chinese Healthy Male Subjects

Not yet recruitingNCT06641388

AkesoHealthy Subjects (HS)

Start: 2024-11-04End: 2025-06-17Target: 180Updated: 2024-10-15

A Study Evaluating the Single Subcutaneous Injection of Ebronucimab in Healthy Male Chinese Subjects

CompletedNCT07043283

AkesoHealthy Subjects

Start: 2025-10-20End: 2026-02-07Updated: 2026-06-26